Page 80 - Read Online

Tian et al. Microbiome Res Rep 2024;3:49 https://dx.doi.org/10.20517/mrr.2024.33 Page 13 of 14

Copyright
© The Author(s) 2024.

REFERENCES
1. Freeman M. The World Mental Health Report: transforming mental health for all. World Psychiatry 2022;21:391-2. DOI PubMed
PMC
2. Mazza MG, Palladini M, Poletti S, Benedetti F. Post-COVID-19 depressive symptoms: epidemiology, pathophysiology, and
pharmacological treatment. CNS Drugs 2022;36:681-702. DOI PubMed PMC
3. Penninx BW, Milaneschi Y, Lamers F, Vogelzangs N. Understanding the somatic consequences of depression: biological mechanisms
and the role of depression symptom profile. BMC Med 2013;11:129. DOI PubMed PMC
4. Spellman T, Liston C. Toward circuit mechanisms of pathophysiology in depression. Am J Psychiatry 2020;177:381-90. DOI
PubMed PMC
5. Cipriani A, Furukawa TA, Salanti G, et al. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of
adults with major depressive disorder: a systematic review and network meta-analysis. Focus 2018;16:420-9. DOI PubMed PMC
6. Raes J. Nifty new tools for microbiome treatment design. Nat Rev Gastroenterol Hepatol 2023;20:77-8. DOI PubMed
7. Strandwitz P. Neurotransmitter modulation by the gut microbiota. Brain Res 2018;1693:128-33. DOI PubMed PMC
8. Barandouzi ZA, Starkweather AR, Henderson WA, Gyamfi A, Cong XS. Altered composition of gut microbiota in depression: a
systematic review. Front Psychiatry 2020;11:541. DOI PubMed PMC
9. Simpson CA, Diaz-Arteche C, Eliby D, Schwartz OS, Simmons JG, Cowan CSM. The gut microbiota in anxiety and depression - a
systematic review. Clin Psychol Rev 2021;83:101943. DOI PubMed
10. Tian P, Chen Y, Zhu H, et al. Bifidobacterium breve CCFM1025 attenuates major depression disorder via regulating gut microbiome
and tryptophan metabolism: a randomized clinical trial. Brain Behav Immun 2022;100:233-41. DOI PubMed
11. Zhu F, Guo R, Wang W, et al. Transplantation of microbiota from drug-free patients with schizophrenia causes schizophrenia-like
abnormal behaviors and dysregulated kynurenine metabolism in mice. Mol Psychiatry 2020;25:2905-18. DOI PubMed
12. Baske MM, Timmerman KC, Garmo LG, Freitas MN, McCollum KA, Ren TY. Fecal microbiota transplant on Escherichia-Shigella
gut composition and its potential role in the treatment of generalized anxiety disorder: a systematic review. J Affect Disord
2024;354:309-17. DOI PubMed
13. Doll JPK, Vázquez-Castellanos JF, Schaub AC, et al. Fecal microbiota transplantation (FMT) as an adjunctive therapy for depression -
case report. Front Psychiatry 2022;13:815422. DOI PubMed PMC
14. Carlson PE Jr. Regulatory considerations for fecal microbiota transplantation products. Cell Host Microbe 2020;27:173-5. DOI
PubMed
15. Kazem YI, Mahmoud MH, Essa HA, et al. Role of Bifidobacterium spp. intake in improving depressive mood and well-being and its
link to kynurenine blood level: an interventional study. J Complement Integr Med 2023;20:223-32. DOI PubMed
16. Qian X, Tian P, Guo M, et al. Determining the emotional regulation function of Bifidobacterium breve: the role of gut metabolite
regulation over colonization capability. Food Funct 2024;15:1598-611. DOI PubMed
17. Dinan TG, Stanton C, Cryan JF. Psychobiotics: a novel class of psychotropic. Biol Psychiatry 2013;74:720-6. DOI PubMed
18. Knuesel T, Mohajeri MH. The role of the gut microbiota in the development and progression of major depressive and bipolar disorder.
Nutrients 2021;14:37. DOI PubMed PMC
19. Tian P, Zou R, Wang L, et al. Multi-probiotics ameliorate major depressive disorder and accompanying gastrointestinal syndromes via
serotonergic system regulation. J Adv Res 2023;45:117-25. DOI PubMed PMC
20. Majeed M, Nagabhushanam K, Arumugam S, Majeed S, Ali F. Bacillus coagulans MTCC 5856 for the management of major
depression with irritable bowel syndrome: a randomised, double-blind, placebo controlled, multi-centre, pilot clinical study. Food Nutr
Res 2018;62. DOI PubMed PMC
21. Zung WW. A rating instrument for anxiety disorders. Psychosomatics 1971;12:371-9. DOI PubMed
22. Beekman E, Verhagen A. Clinimetrics: hospital anxiety and depression scale. J Physiother 2018;64:198. DOI PubMed
23. Buysse DJ, Hall ML, Strollo PJ, et al. Relationships between the Pittsburgh Sleep Quality Index (PSQI), Epworth Sleepiness Scale
(ESS), and clinical/polysomnographic measures in a community sample. J Clin Sleep Med 2008;4:563-71. PubMed PMC
24. Svedlund J, Sjödin I, Dotevall G. GSRS - a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome
and peptic ulcer disease. Dig Dis Sci 1988;33:129-34. DOI PubMed
25. Riemann D, Voderholzer U. Primary insomnia: a risk factor to develop depression? J Affect Disord 2003;76:255-9. DOI PubMed
26. Zhang AZ, Wang QC, Huang KM, et al. Prevalence of depression and anxiety in patients with chronic digestive system diseases: a
multicenter epidemiological study. World J Gastroenterol 2016;22:9437-44. DOI PubMed PMC
27. Díaz-Perdigones CM, Muñoz-Garach A, Álvarez-Bermúdez MD, Moreno-Indias I, Tinahones FJ. Gut microbiota of patients with type
2 diabetes and gastrointestinal intolerance to metformin differs in composition and functionality from tolerant patients. Biomed
Pharmacother 2022;145:112448. DOI PubMed
28. Zhou J, Zhang Q, Zhao Y, et al. The relationship of Megamonas species with nonalcoholic fatty liver disease in children and
adolescents revealed by metagenomics of gut microbiota. Sci Rep 2022;12:22001. DOI PubMed PMC
29. Zhao RH, Zheng PY, Liu SM, et al. [Correlation between gut microbiota and behavior symptoms in children with autism spectrum